Month: <span>June 2018</span>

Home / 2018 / June
Post

Trump administration is shutting down practice-guidelines clearinghouse for doctors

Diagnostic and treatment guidelines aren’t sexy, but they play a vital role in the practice of medicine. Physician societies, government agencies, and others issue detailed recommendations for everything from who should receive cardiac stents to which antibiotics patients should get to avoid infections after knee surgery. These documents are essential for the provision of evidence-based care, as...

Post

Researchers pinpoint new subtype of prostate cancer

Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting precision medicine approach MICHIGAN MEDICINE – UNIVERSITY OF MICHIGAN IMAGE: DEPICTION OF THE MOLECULAR PROCESSES INVOLVED IN A NEW SUBTYPE OF METASTATIC PROSTATE CANCER CHARACTERIZED BY LOSS OF THE GENE CDK12. CREDIT: ALEXANDER TOKAREV, ELLA MARU STUDIO ANN ARBOR, Michigan — Researchers led...

Post

MD Anderson, Houston Methodist scientists detect new ovarian cancer target

Preclinical research shows malignant cells’ tie to supportive fibroblasts can be hit with Calcitriol UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium...

Post

Spatial memory patterns mapped

Researchers at Cardiff University have mapped out how we store long-term spatial memory, shedding light on how our brains remember where things are within our surroundings. Professor Frank Sengpiel, from Cardiff University’s School of Biosciences, said: “Until now, how the brain stores information about our environment over long periods of time has been a mystery....

Post

World-first test could predict risk of heart attack in coronary artery disease patients

Researchers have developed a world-first blood test which improves the prediction of the long-term risk of heart attack or death in those with severe coronary artery disease. A new blood test could help those with severe coronary artery disease. Credit: University of Melbourne The Austin Health and University of Melbourne study published in PLOS ONE today, found...

Post

Combining NSAIDs and TNFi may reduce radiographic progression in ankylosing spondylitis

June 14, 2018, European League Against Rheumatism The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients with ankylosing spondylitis (AS) taking tumour necrosis factor (TNF) inhibitors, the addition of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with significantly less radiographic progression in a dose-related manner at...

Post

Access to investigational medicines for terminally ill through expanded access programs

Bottom Line: A new study identified investigational medicines made available through expanded access programs for patients with life-threatening illnesses prior to approval from the U.S. Food and Drug Administration to assess the timing and duration of investigational drug availability. Authors: Joseph S. Ross, M.D., M.H.S., of Yale University School of Medicine, New Haven, Connecticut, and coauthors To Learn...

Post

Clinical advances in systemic lupus erythematosus

New data on a promising biological treatment and successful use of shingles vaccine EUROPEAN LEAGUE AGAINST RHEUMATISM The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate exciting advances for individuals suffering from systemic lupus erythematosus (SLE).1,2 The first is a phase II clinical study of a promising oral treatment,...